Revision 4

#52113Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB

REACTIVITY:

H M

SENSITIVITY:

Endogenous

MW (kDa):

28

Source/Isotype:

Rabbit IgG

UniProt ID:

#O14543

Entrez-Gene Id:

9021

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

SOCS3 (D6E1T) Rabbit mAb recognizes endogenous levels of total SOCS3 protein.

Species Reactivity:

Human, Mouse

Source / Purification

Monoclonal antibody is produced by immunizing animals with recombinant protein specific to human SOCS3 protein.

Background

The suppressor of cytokine signaling (SOCS) family members are negative regulators of cytokine signal transduction that inhibit the Jak/Stat pathway (1-3). The SOCS family consists of at least 8 members including the originally identified cytokine-inducible SH2-containing protein (CIS1), as well as SOCS1-7. Each SOCS family member contains a central SH2 domain and a conserved carboxy-terminal motif designated as the SOCS box. These proteins are important regulators of cytokine signaling, proliferation, differentiation, and immune responses.
Low levels of SOCS3 are observed in lung, spleen, and thymus and, like other SOCS family members, its expression is rapidly induced by a number of factors including interleukins, EPO, IFN-γ, CSF, and TNF-α (4). SOCS3 uses its SH2 domain to bind activated Jaks and their cognate receptors to provide negative feedback inhibition. In addition to the initially described inducers of SOCS3 expression, subsequent studies have described SOCS3-mediated negative feedback inhibition for leptin (5), GH (6), chemokine receptors (7), insulin (8), and certain pathogens (9,10). SOCS3 deletion results in embryonic lethality with placental insufficiency (11). SOCS3 signaling has been linked pathologically to allergic responses (12), inflammatory disease (13), endotoxic shock (14), wound repair (15), and obesity (16,17).

  1. Alexander, W.S. et al. (1999) J Leukoc Biol 66, 588-92.
  2. Chen, X.P. et al. (2000) Immunity 13, 287-90.
  3. Hilton, D.J. et al. (1998) Proc Natl Acad Sci USA 95, 114-9.
  4. Starr, R. et al. (1997) Nature 387, 917-21.
  5. Bjørbaek, C. et al. (1998) Mol Cell 1, 619-25.
  6. Adams, T.E. et al. (1998) J Biol Chem 273, 1285-7.
  7. Soriano, S.F. et al. (2002) J Exp Med 196, 311-21.
  8. Emanuelli, B. et al. (2000) J Biol Chem 275, 15985-91.
  9. Stoiber, D. et al. (1999) J Immunol 163, 2640-7.
  10. Stoiber, D. et al. (2001) J Immunol 166, 466-72.
  11. Roberts, A.W. et al. (2001) Proc Natl Acad Sci U S A 98, 9324-9.
  12. Seki, Y. et al. (2003) Nat Med 9, 1047-54.
  13. Shouda, T. et al. (2001) J Clin Invest 108, 1781-8.
  14. Fang, M. et al. (2005) Cell Mol Immunol 2, 373-7.
  15. Goren, I. et al. (2006) J Invest Dermatol 126, 477-85.
  16. Mori, H. et al. (2004) Nat Med 10, 739-43.
  17. Howard, J.K. et al. (2004) Nat Med 10, 734-8.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
KARPAS cell line source: Dr. Abraham Karpas at the University of Cambridge.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

限制使用

除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。

专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专

Revision 4
#52113

SOCS3 (D6E1T) Rabbit mAb

Western Blotting Image 1: SOCS3 (D6E1T) Rabbit mAb Expand Image
使用 SOCS3 (D6E1T) 兔单克隆抗体(上图)或 β-肌动蛋白 (D6A8) 兔单克隆抗体#8457(下图)对未经 (-) 或已经 Human Oncostatin M #5367(hOSM;20 ng/ml,1 小时;+)处理的 Hep G2 和 A-375 细胞系的提取物进行蛋白印迹分析。
Western Blotting Image 2: SOCS3 (D6E1T) Rabbit mAb Expand Image
使用 SOCS3 (D6E1T) 兔单克隆抗体对转染空载 (-) 或转染表达全长人 SOCS3 (+) 的表达载体的 293T 细胞的提取物进行蛋白印迹分析。
Western Blotting Image 3: SOCS3 (D6E1T) Rabbit mAb Expand Image
使用 SOCS3 (D6E1T) 兔单克隆抗体(上图)或 β-肌动蛋白 (D6A8) 兔单克隆抗体(下图)对未经 (-) 或已经 Jak3 抑制剂 WHI-P154(40 μM,过夜;+)处理的 KARPAS-299 细胞的提取物进行蛋白印迹分析。KARPAS 细胞系来源:剑桥大学 Abraham Karpas 博士。
Western Blotting Image 4: SOCS3 (D6E1T) Rabbit mAb Expand Image
使用 SOCS3 (D6E1T) 兔单克隆抗体(上图)或 GAPDH (D16H11) XP® 兔单克隆抗体#5174(下图)对未经 (-) 或已经 Lipopolysaccharides #14011(LPS;50 ng/ml,4 小时;+)处理的小鼠骨髓源性巨噬细胞 (mBMDM) 的细胞提取物进行蛋白印迹分析。